Here, we demonstrate the proapoptotic and antinociceptive effect of NK-1R blockade in human myeloid leukemia cells and mouse models, implicating the potential multifactorial effects of NK-1R antagonists in human leukemia treatment. This evidence concerns the gene TACR1 and leukemia.